Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified
Conditions
Interventions
Intervention1: Tablet Mycophenolate mofetil 500 mg: Tablet Mycophenolate mofetil 500 mg two tablets twice daily for one month and after follow up dose reduced to tablet Mycophenolate mofetil one table
Sponsors
Dr Mahuya Giri
Dr Satya Ranjan Misra
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed with erosive/ ulcerative oral lichen planus clinically. 2. Patient who are recalcitrant to topical modalities for erosive oral lichen planus more than 3 months.
Exclusion criteria
Exclusion criteria: 1. Patients not willing to be a part of the study. 2. Pregnant or breast-feeding women. 3. Any systemic or dermal disease or simultaneous use of other drugs affecting the immune system of the patient. 4. Patient having any other oral mucosal disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in the pain score, reduction in burning sensation, decrease in the size of the lesion. Complete clinical resolution of the lesion and remission. Timepoint: at baseline, 1 month and 2 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in the pain score, reduction in burning sensation, decrease in the size of the lesion. Complete clinical resolution of the lesion & remission. Timepoint: 2 years | — |
Countries
India
Contacts
Public ContactDr Mahuya Giri
Institute of Dental Sciences, Bhubaneswar
Outcome results
None listed